News
Walmart is expanding healthcare benefits for eligible US employees in 2027, introducing more than 250 prescription medications at no cost, specialist services for rare conditions and additional paid NICU leave. The changes come as employers face rising insurance costs and growing pressure to improve access to affordable healthcare.
Experimental peptides are gaining attention across the United States as consumers seek new treatments for weight loss, recovery and longevity. However, limited human clinical evidence and changing FDA regulations present difficult questions for healthcare providers. Recent reporting and physician surveys reveal a growing divide between consumer demand and established medical standards.
Nearly 71% of Medicare Advantage members are enrolled in plans rated four stars or higher for 2027, according to CMS. However, only 37% of contracts achieved that standard. The results reveal differences in plan quality and could have significant financial implications for insurers as they prepare for changes to federal quality bonus payments in 2028.









